Quick Answer
Tevogen Bio Holdings Inc. reported Net Income of -$26.28 million for fiscal year 2025.
Tevogen Bio Holdings Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$26.28M | -91.4% |
| 2024 | -$13.73M | +77.3% |
| 2023 | -$60.48M | -1471.9% |
| 2022 | $4.41M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$5.73M | +2.7% | -4.0% |
| June 30, 2025 | -$5.50M | +43.0% | +46.9% |
| March 31, 2025 | -$10.37M | -192.0% | -76.2% |
| September 30, 2024 | -$5.88M | -50.7% | +39.1% |
| June 30, 2024 | -$9.66M | +56.4% | -185.8% |
| March 31, 2024 | $11.26M | +136.6% | +388.5% |
| September 30, 2023 | -$3.90M | -342.1% | +82.4% |
| June 30, 2023 | -$22.18M | -10817.2% | +27.9% |
- Tevogen Bio Holdings Inc. showed a decrease of -91.4% in Net Income compared to the prior fiscal year.
- Over the 2022–2025 period, Tevogen Bio Holdings Inc.’s net income has declined by 696.0% (from $4.41 million to -$26.28 million).
- The most recent figure is from Tevogen Bio Holdings Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: